Correction
for Correale* et al., J Immunol 175 (2) 820-828.
The Journal of Immunology, 2005, 175: 6235.
Copyright © 2005 by The American Association of Immunologists
Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
P. Correale,
M. G. Cusi,
M. T. Del Vecchio,
A. Aquino,
S. Prete,
K. Y. Tsang,
L. Micheli,
C. Nencini,
M. La Placa,
F. Montagnani,
C. Terrosi,
M. Caraglia,
V. Formica,
G. Giorgi,
E. Bonmassar and
G. Francini
Correale, P., M. G. Cusi, M. T. Del Vecchio, A. Aquino, S. Prete, K. Y. Tsang, L. Micheli, C. Nencini, M. La Placa, F. Montagnani, C. Terrosi, M. Caraglia, V. Formica, G. Giorgi, E. Bonmassar, and G. Francini. 2005. Dendritic cell-mediated cross-presentation of Ags derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human Ag-specific CTL response with antitumor activity in vitro. J. Immunol. 175: 820–828
.
The fifth author’s name is listed incorrectly. The correct name is Salvatore Pasquale Prete.
There is an error in the grant information. The correct footnote is shown below.
1This work was supported in part by a grant from "Istituto Superiore di Sanità" no. 1A2/F7 (Research Unit, to E.B.) and in part by a grant of MIUR "Programma di Ricerca Scientifica di rilevante interesse Nazionale" 2004 (coordinator E.B.).
